个人化基因组

最新新闻

• 评级变动
  Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Cuts Target Price to $8.93
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• 评级变动
  Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Cuts Target Price to $5.78
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Guggenheim Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Needham Maintains Personalis(PSNL.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• Needham Downgrades Personalis(PSNL.US) to Hold Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/7/21
• 评级变动
  A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $11 to $13
  \u5e02\u573a\u8d44\u8baf · 2026/2/28
• 评级变动
  Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/20
• 评级变动
  TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  Needham Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• Lake Street Downgrades Personalis(PSNL.US) to Hold Rating, Raises Target Price to $16.25
  \u5e02\u573a\u8d44\u8baf · 2026/7/21
• 评级变动
  Lake Street Initiates Personalis(PSNL.US) With Buy Rating, Announces Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Craig-Hallum Maintains Personalis(PSNL.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/22
• BTIG Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $16.25
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• BTIG Downgrades Personalis(PSNL.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• 评级变动
  BTIG Maintains Personalis(PSNL.US) With Buy Rating, Cuts Target Price to $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Cuts Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Needham Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• Lake Street Maintains Personalis(PSNL.US) With Hold Rating, Maintains Target Price $16.25
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Needham Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/7/17

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。